elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Institutions
beta
Research Intelligence
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Angiosarcoma
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Angiosarcoma
RIS
0.000
(Research Intensity Score)
Papers
84
Top papers
The Minderoo-Monaco Commission on Plastics and Human Health
2023 · 463 citations
Boron neutron capture therapy for cutaneous angiosarcoma and malignant melanoma: First in-human phase I clinical trial
2025 · 26 citations
Scalp angiosarcoma treated with linear accelerator-based boron neutron capture therapy: A report of two patients
2022 · 47 citations
Environmental risk factors for liver cancer
2025 · 12 citations
Advances in Clinical Trials of Boron Neutron Capture Therapy
2026 · 7 citations
Newest papers
Advances in Clinical Trials of Boron Neutron Capture Therapy
2026 · 7 citations
Cutaneous Angiosarcoma Mimicking an Inflammatory Scalp Lesion: Diagnostic Insight from Dermoscopy, Tzanck Smear, and Immunohistochemical Analysis
2026
Primary Angiosarcoma of the Abdominal Aorta Following Endovascular Aneurysm Repair Mimicking Vascular Graft Infection
2026
The boron uptake via LAT1 and survival analysis after boron neutron capture therapy in canine hemangiosarcoma cell lines
2026
Boron neutron capture therapy for cutaneous angiosarcoma and malignant melanoma: First in-human phase I clinical trial
2025 · 26 citations
A sample from the 84 top papers behind Angiosarcoma.
Create a free account to browse them all →
Angiosarcoma's history
Research intensity over time
Explore Angiosarcoma's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Angiosarcoma's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link